BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronate. (Q44432504)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronate (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Kristine Ensrud

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

10

Dennis M Black

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

3

Ann V Schwartz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

5

Douglas C Bauer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

8

Arthur Santora

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Elizabeth Barrett-Connor

9

object named as

Elizabeth Barrett-Connor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Brian Louis McNabb

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Eric Vittinghoff

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Elizabeth Rosenberg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

1 reference

1 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

Journal of Bone and Mineral Research

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

1319-1327

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

The economic and human costs of osteoporotic fracture

23 February 2020

cites work

1 reference

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group

21 January 2018

1 reference

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

21 January 2018

1 reference

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

21 January 2018

1 reference

Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women

21 January 2018

1 reference

Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension

21 January 2018

1 reference

Ten years' experience with alendronate for osteoporosis in postmenopausal women

21 January 2018

1 reference

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

21 January 2018

1 reference

The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT).

21 January 2018

1 reference

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

21 January 2018

1 reference

Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure

21 January 2018

1 reference

Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate

21 January 2018

1 reference

Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research

21 January 2018

1 reference

Bisphosphonates for osteoporosis--where do we go from here?

21 January 2018

1 reference

Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial

21 January 2018

1 reference

Continuing bisphosphonate treatment for osteoporosis--for whom and for how long?

21 January 2018

1 reference

Updated data on proximal femur bone mineral levels of US adults

21 January 2018

1 reference

Effects of a new positioner on the precision of hip bone mineral density measurements

21 January 2018

1 reference

Evaluation of dual-energy X-ray absorptiometry bone mineral measurement--comparison of a single-beam and fan-beam design: the effect of osteophytic calcification on spine bone mineral density

21 January 2018

1 reference

Pharmacokinetics of alendronate

21 January 2018

1 reference

Radiographic features of lumbar disc degeneration and bone mineral density in men and women.

21 January 2018

1 reference

Vertebral spinal osteophytes

21 January 2018

1 reference

Changes in bone density and turnover after alendronate or estrogen withdrawal.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JBMR.1864

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23408577%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference